Beyond the MEP pathway: a novel kinase required for prenol utilization by malária parasites

Abstract: A proposed treatment for malaria is a combination of fosmidomycin and clindamycin. Both compounds inhibit the methylerythritol 4-phosphate (MEP) pathway, the parasitic source of farnesyl and geranylgeranyl pyrophosphate (FPP and GGPP, respectively). Both FPP and GGPP are crucial for the biosynthesis of several essential metabolites such as ubiquinone and Leia mais…

INSCREVA-se em nossa newsletter

Receba nossas novidades em seu e-mail.

SUBSCRIBE to our newsletter

Receive our news in your email.

Pular para o conteúdo